Please login to the form below

Not currently logged in
Email:
Password:

Lupin names chief corporate development officer

Theresa Stevens has experience at Novartis and Aptalis

Lupin Theresa StevensLupin has appointed Theresa Stevens as chief corporate development officer for its global operations.

Stevens joins the India-based pharma company from Aptalis Pharma, where she was chief corporate development officer for mergers and acquisitions, strategy and global business development.

Prior to this Steven spent nine years at Novartis, serving in such roles as head of global business development and licensing.

She holds degrees in both biochemisty and law, and has previously worked as a research scientist at Dupont and as a lawyer at Pennie & Edmonds.

Lupin's decision to hire Stevens follows its appointment earlier this year of Teva's Dr Maurice Chagnaud as president, Europe, and head of inhalation strategy.

According to the company, these hires are part of a push to expand the company beyond its home market by improving its performance in the US, Europe and key emerging markets.

25th April 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics